You just read:

Cellect Announces a Major Breakthrough of its ApoGraft™ Technology: Reporting Today Positive Results from a 20 Patients Trial With Tel-Aviv Ichilov Medical Center

News provided by

Cellect Biotechnology Ltd.

Oct 25, 2017, 07:00 ET